Advances in nanomedicines for malaria treatment
Malaria is an infectious disease that mainly affects children and pregnant women from tropical countries. The mortality rate of people infected with malaria per year is enormous and became a public health concern. The main factor that has contributed to the success of malaria proliferation is the in...
Gespeichert in:
| Veröffentlicht in: | Advances in colloid and interface science 2013-12, Vol.201-202, p.1-17 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 17 |
|---|---|
| container_issue | |
| container_start_page | 1 |
| container_title | Advances in colloid and interface science |
| container_volume | 201-202 |
| creator | Aditya, N.P. Vathsala, P.G. Vieira, V. Murthy, R.S.R. Souto, E.B. |
| description | Malaria is an infectious disease that mainly affects children and pregnant women from tropical countries. The mortality rate of people infected with malaria per year is enormous and became a public health concern. The main factor that has contributed to the success of malaria proliferation is the increased number of drug resistant parasites. To counteract this trend, research has been done in nanotechnology and nanomedicine, for the development of new biocompatible systems capable of incorporating drugs, lowering the resistance progress, contributing for diagnosis, control and treatment of malaria by target delivery. In this review, we discussed the main problems associated with the spread of malaria and the most recent developments in nanomedicine for anti-malarial drug delivery.
The main factor that contributes to the success of malaria proliferation is the increased number of drug resistant parasites. To counteract this trend, research has been done in nanotechnology and nanomedicine, for the development of new biocompatible systems capable of incorporating drugs, lowering the resistance progress, contributing for diagnosis, control and treatment of malaria by target delivery. This scheme represents the sequential steps involved in the development of anti-malarial drugs. [Display omitted]
•Nanomedicine has contributed to the development of therapies for Malaria.•Colloidal carriers are able to lower the drug resistance progress, contributing to diagnosis.•Advanced colloidal carriers can be used to overcome multi-drug resistance. |
| doi_str_mv | 10.1016/j.cis.2013.10.014 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1730050577</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0001868613001292</els_id><sourcerecordid>1551626228</sourcerecordid><originalsourceid>FETCH-LOGICAL-c486t-441b8d6f17e2adeac2331759e6df237f89e551b4e28577e154a447cc39fcaf553</originalsourceid><addsrcrecordid>eNqFkMtKAzEUhoMotlYfwI3MRnAz09wzg6tSvEHBja5DmjmBlLnUZFrw7c3Q2qWuwjl8_3_Ch9AtwQXBRM43hfWxoJiwNBeY8DM0JaViOVNUnaMpxpjkpSzlBF3FuEkjFUpcognlpKJYsimaL-q96SzEzHdZZ7q-hdpb36WF60PWmsYEb7IhgBla6IZrdOFME-Hm-M7Q5_PTx_I1X72_vC0Xq9zyUg4552Rd1tIRBdTUYCxljChRgawdZcqVFQhB1hxoKZQCIrjhXFnLKmeNE4LN0MOhdxv6rx3EQbc-Wmga00G_i5oohrHAKfw_mi5JKiktE0oOqA19jAGc3gbfmvCtCdajUr3RSakelY6rpDRl7o71u3WSc0r8OkzA_REw0ZrGheQzdZw4VUnF5Xj88cBB8rb3EHS0HpL72gewg657_8c3fgDs1JGr</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1551626228</pqid></control><display><type>article</type><title>Advances in nanomedicines for malaria treatment</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Aditya, N.P. ; Vathsala, P.G. ; Vieira, V. ; Murthy, R.S.R. ; Souto, E.B.</creator><creatorcontrib>Aditya, N.P. ; Vathsala, P.G. ; Vieira, V. ; Murthy, R.S.R. ; Souto, E.B.</creatorcontrib><description>Malaria is an infectious disease that mainly affects children and pregnant women from tropical countries. The mortality rate of people infected with malaria per year is enormous and became a public health concern. The main factor that has contributed to the success of malaria proliferation is the increased number of drug resistant parasites. To counteract this trend, research has been done in nanotechnology and nanomedicine, for the development of new biocompatible systems capable of incorporating drugs, lowering the resistance progress, contributing for diagnosis, control and treatment of malaria by target delivery. In this review, we discussed the main problems associated with the spread of malaria and the most recent developments in nanomedicine for anti-malarial drug delivery.
The main factor that contributes to the success of malaria proliferation is the increased number of drug resistant parasites. To counteract this trend, research has been done in nanotechnology and nanomedicine, for the development of new biocompatible systems capable of incorporating drugs, lowering the resistance progress, contributing for diagnosis, control and treatment of malaria by target delivery. This scheme represents the sequential steps involved in the development of anti-malarial drugs. [Display omitted]
•Nanomedicine has contributed to the development of therapies for Malaria.•Colloidal carriers are able to lower the drug resistance progress, contributing to diagnosis.•Advanced colloidal carriers can be used to overcome multi-drug resistance.</description><identifier>ISSN: 0001-8686</identifier><identifier>EISSN: 1873-3727</identifier><identifier>DOI: 10.1016/j.cis.2013.10.014</identifier><identifier>PMID: 24192063</identifier><identifier>CODEN: ACISB9</identifier><language>eng</language><publisher>Amsterdam: Elsevier B.V</publisher><subject>Animals ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Antimalarials - administration & dosage ; Antiparasitic agents ; Biocompatible Materials - chemistry ; Biological and medical sciences ; Child ; Clinical Trials as Topic ; Colloidal carriers ; Colloids - chemistry ; Control systems ; Cross-disciplinary physics: materials science; rheology ; Culicidae ; Dendrimers ; Dendrimers - chemistry ; Drug Delivery Systems ; Drug Discovery ; Drug Resistance, Multiple ; Drugs ; Exact sciences and technology ; Female ; Genetic Therapy ; Humans ; Lipids ; Lipids - chemistry ; Liposomes ; Liposomes - chemistry ; Malaria ; Malaria - drug therapy ; Malaria Vaccines - therapeutic use ; Male ; Materials science ; Medical sciences ; Microfluidics ; Mortality ; Nanomedicine ; Nanomedicine - trends ; Nanoparticles - chemistry ; Nanoscale materials and structures: fabrication and characterization ; Nanostructure ; Pharmacology. Drug treatments ; Physics ; Plasmodium ; Plasmodium - metabolism ; Polymers ; Polymers - chemistry ; Pregnancy ; Public health ; Solid lipid nanoparticles ; Spreads ; Toxicity</subject><ispartof>Advances in colloid and interface science, 2013-12, Vol.201-202, p.1-17</ispartof><rights>2013 Elsevier B.V.</rights><rights>2015 INIST-CNRS</rights><rights>2013.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c486t-441b8d6f17e2adeac2331759e6df237f89e551b4e28577e154a447cc39fcaf553</citedby><cites>FETCH-LOGICAL-c486t-441b8d6f17e2adeac2331759e6df237f89e551b4e28577e154a447cc39fcaf553</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0001868613001292$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=27967468$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24192063$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Aditya, N.P.</creatorcontrib><creatorcontrib>Vathsala, P.G.</creatorcontrib><creatorcontrib>Vieira, V.</creatorcontrib><creatorcontrib>Murthy, R.S.R.</creatorcontrib><creatorcontrib>Souto, E.B.</creatorcontrib><title>Advances in nanomedicines for malaria treatment</title><title>Advances in colloid and interface science</title><addtitle>Adv Colloid Interface Sci</addtitle><description>Malaria is an infectious disease that mainly affects children and pregnant women from tropical countries. The mortality rate of people infected with malaria per year is enormous and became a public health concern. The main factor that has contributed to the success of malaria proliferation is the increased number of drug resistant parasites. To counteract this trend, research has been done in nanotechnology and nanomedicine, for the development of new biocompatible systems capable of incorporating drugs, lowering the resistance progress, contributing for diagnosis, control and treatment of malaria by target delivery. In this review, we discussed the main problems associated with the spread of malaria and the most recent developments in nanomedicine for anti-malarial drug delivery.
The main factor that contributes to the success of malaria proliferation is the increased number of drug resistant parasites. To counteract this trend, research has been done in nanotechnology and nanomedicine, for the development of new biocompatible systems capable of incorporating drugs, lowering the resistance progress, contributing for diagnosis, control and treatment of malaria by target delivery. This scheme represents the sequential steps involved in the development of anti-malarial drugs. [Display omitted]
•Nanomedicine has contributed to the development of therapies for Malaria.•Colloidal carriers are able to lower the drug resistance progress, contributing to diagnosis.•Advanced colloidal carriers can be used to overcome multi-drug resistance.</description><subject>Animals</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Antimalarials - administration & dosage</subject><subject>Antiparasitic agents</subject><subject>Biocompatible Materials - chemistry</subject><subject>Biological and medical sciences</subject><subject>Child</subject><subject>Clinical Trials as Topic</subject><subject>Colloidal carriers</subject><subject>Colloids - chemistry</subject><subject>Control systems</subject><subject>Cross-disciplinary physics: materials science; rheology</subject><subject>Culicidae</subject><subject>Dendrimers</subject><subject>Dendrimers - chemistry</subject><subject>Drug Delivery Systems</subject><subject>Drug Discovery</subject><subject>Drug Resistance, Multiple</subject><subject>Drugs</subject><subject>Exact sciences and technology</subject><subject>Female</subject><subject>Genetic Therapy</subject><subject>Humans</subject><subject>Lipids</subject><subject>Lipids - chemistry</subject><subject>Liposomes</subject><subject>Liposomes - chemistry</subject><subject>Malaria</subject><subject>Malaria - drug therapy</subject><subject>Malaria Vaccines - therapeutic use</subject><subject>Male</subject><subject>Materials science</subject><subject>Medical sciences</subject><subject>Microfluidics</subject><subject>Mortality</subject><subject>Nanomedicine</subject><subject>Nanomedicine - trends</subject><subject>Nanoparticles - chemistry</subject><subject>Nanoscale materials and structures: fabrication and characterization</subject><subject>Nanostructure</subject><subject>Pharmacology. Drug treatments</subject><subject>Physics</subject><subject>Plasmodium</subject><subject>Plasmodium - metabolism</subject><subject>Polymers</subject><subject>Polymers - chemistry</subject><subject>Pregnancy</subject><subject>Public health</subject><subject>Solid lipid nanoparticles</subject><subject>Spreads</subject><subject>Toxicity</subject><issn>0001-8686</issn><issn>1873-3727</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkMtKAzEUhoMotlYfwI3MRnAz09wzg6tSvEHBja5DmjmBlLnUZFrw7c3Q2qWuwjl8_3_Ch9AtwQXBRM43hfWxoJiwNBeY8DM0JaViOVNUnaMpxpjkpSzlBF3FuEkjFUpcognlpKJYsimaL-q96SzEzHdZZ7q-hdpb36WF60PWmsYEb7IhgBla6IZrdOFME-Hm-M7Q5_PTx_I1X72_vC0Xq9zyUg4552Rd1tIRBdTUYCxljChRgawdZcqVFQhB1hxoKZQCIrjhXFnLKmeNE4LN0MOhdxv6rx3EQbc-Wmga00G_i5oohrHAKfw_mi5JKiktE0oOqA19jAGc3gbfmvCtCdajUr3RSakelY6rpDRl7o71u3WSc0r8OkzA_REw0ZrGheQzdZw4VUnF5Xj88cBB8rb3EHS0HpL72gewg657_8c3fgDs1JGr</recordid><startdate>20131201</startdate><enddate>20131201</enddate><creator>Aditya, N.P.</creator><creator>Vathsala, P.G.</creator><creator>Vieira, V.</creator><creator>Murthy, R.S.R.</creator><creator>Souto, E.B.</creator><general>Elsevier B.V</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>C1K</scope><scope>F1W</scope><scope>H95</scope><scope>H97</scope><scope>L.G</scope><scope>M7N</scope><scope>7U5</scope><scope>8FD</scope><scope>L7M</scope></search><sort><creationdate>20131201</creationdate><title>Advances in nanomedicines for malaria treatment</title><author>Aditya, N.P. ; Vathsala, P.G. ; Vieira, V. ; Murthy, R.S.R. ; Souto, E.B.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c486t-441b8d6f17e2adeac2331759e6df237f89e551b4e28577e154a447cc39fcaf553</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Animals</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Antimalarials - administration & dosage</topic><topic>Antiparasitic agents</topic><topic>Biocompatible Materials - chemistry</topic><topic>Biological and medical sciences</topic><topic>Child</topic><topic>Clinical Trials as Topic</topic><topic>Colloidal carriers</topic><topic>Colloids - chemistry</topic><topic>Control systems</topic><topic>Cross-disciplinary physics: materials science; rheology</topic><topic>Culicidae</topic><topic>Dendrimers</topic><topic>Dendrimers - chemistry</topic><topic>Drug Delivery Systems</topic><topic>Drug Discovery</topic><topic>Drug Resistance, Multiple</topic><topic>Drugs</topic><topic>Exact sciences and technology</topic><topic>Female</topic><topic>Genetic Therapy</topic><topic>Humans</topic><topic>Lipids</topic><topic>Lipids - chemistry</topic><topic>Liposomes</topic><topic>Liposomes - chemistry</topic><topic>Malaria</topic><topic>Malaria - drug therapy</topic><topic>Malaria Vaccines - therapeutic use</topic><topic>Male</topic><topic>Materials science</topic><topic>Medical sciences</topic><topic>Microfluidics</topic><topic>Mortality</topic><topic>Nanomedicine</topic><topic>Nanomedicine - trends</topic><topic>Nanoparticles - chemistry</topic><topic>Nanoscale materials and structures: fabrication and characterization</topic><topic>Nanostructure</topic><topic>Pharmacology. Drug treatments</topic><topic>Physics</topic><topic>Plasmodium</topic><topic>Plasmodium - metabolism</topic><topic>Polymers</topic><topic>Polymers - chemistry</topic><topic>Pregnancy</topic><topic>Public health</topic><topic>Solid lipid nanoparticles</topic><topic>Spreads</topic><topic>Toxicity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Aditya, N.P.</creatorcontrib><creatorcontrib>Vathsala, P.G.</creatorcontrib><creatorcontrib>Vieira, V.</creatorcontrib><creatorcontrib>Murthy, R.S.R.</creatorcontrib><creatorcontrib>Souto, E.B.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ASFA: Aquatic Sciences and Fisheries Abstracts</collection><collection>Aquatic Science & Fisheries Abstracts (ASFA) 1: Biological Sciences & Living Resources</collection><collection>Aquatic Science & Fisheries Abstracts (ASFA) 3: Aquatic Pollution & Environmental Quality</collection><collection>Aquatic Science & Fisheries Abstracts (ASFA) Professional</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Solid State and Superconductivity Abstracts</collection><collection>Technology Research Database</collection><collection>Advanced Technologies Database with Aerospace</collection><jtitle>Advances in colloid and interface science</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Aditya, N.P.</au><au>Vathsala, P.G.</au><au>Vieira, V.</au><au>Murthy, R.S.R.</au><au>Souto, E.B.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Advances in nanomedicines for malaria treatment</atitle><jtitle>Advances in colloid and interface science</jtitle><addtitle>Adv Colloid Interface Sci</addtitle><date>2013-12-01</date><risdate>2013</risdate><volume>201-202</volume><spage>1</spage><epage>17</epage><pages>1-17</pages><issn>0001-8686</issn><eissn>1873-3727</eissn><coden>ACISB9</coden><abstract>Malaria is an infectious disease that mainly affects children and pregnant women from tropical countries. The mortality rate of people infected with malaria per year is enormous and became a public health concern. The main factor that has contributed to the success of malaria proliferation is the increased number of drug resistant parasites. To counteract this trend, research has been done in nanotechnology and nanomedicine, for the development of new biocompatible systems capable of incorporating drugs, lowering the resistance progress, contributing for diagnosis, control and treatment of malaria by target delivery. In this review, we discussed the main problems associated with the spread of malaria and the most recent developments in nanomedicine for anti-malarial drug delivery.
The main factor that contributes to the success of malaria proliferation is the increased number of drug resistant parasites. To counteract this trend, research has been done in nanotechnology and nanomedicine, for the development of new biocompatible systems capable of incorporating drugs, lowering the resistance progress, contributing for diagnosis, control and treatment of malaria by target delivery. This scheme represents the sequential steps involved in the development of anti-malarial drugs. [Display omitted]
•Nanomedicine has contributed to the development of therapies for Malaria.•Colloidal carriers are able to lower the drug resistance progress, contributing to diagnosis.•Advanced colloidal carriers can be used to overcome multi-drug resistance.</abstract><cop>Amsterdam</cop><pub>Elsevier B.V</pub><pmid>24192063</pmid><doi>10.1016/j.cis.2013.10.014</doi><tpages>17</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0001-8686 |
| ispartof | Advances in colloid and interface science, 2013-12, Vol.201-202, p.1-17 |
| issn | 0001-8686 1873-3727 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1730050577 |
| source | MEDLINE; Elsevier ScienceDirect Journals |
| subjects | Animals Antibiotics. Antiinfectious agents. Antiparasitic agents Antimalarials - administration & dosage Antiparasitic agents Biocompatible Materials - chemistry Biological and medical sciences Child Clinical Trials as Topic Colloidal carriers Colloids - chemistry Control systems Cross-disciplinary physics: materials science rheology Culicidae Dendrimers Dendrimers - chemistry Drug Delivery Systems Drug Discovery Drug Resistance, Multiple Drugs Exact sciences and technology Female Genetic Therapy Humans Lipids Lipids - chemistry Liposomes Liposomes - chemistry Malaria Malaria - drug therapy Malaria Vaccines - therapeutic use Male Materials science Medical sciences Microfluidics Mortality Nanomedicine Nanomedicine - trends Nanoparticles - chemistry Nanoscale materials and structures: fabrication and characterization Nanostructure Pharmacology. Drug treatments Physics Plasmodium Plasmodium - metabolism Polymers Polymers - chemistry Pregnancy Public health Solid lipid nanoparticles Spreads Toxicity |
| title | Advances in nanomedicines for malaria treatment |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T16%3A33%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Advances%20in%20nanomedicines%20for%20malaria%20treatment&rft.jtitle=Advances%20in%20colloid%20and%20interface%20science&rft.au=Aditya,%20N.P.&rft.date=2013-12-01&rft.volume=201-202&rft.spage=1&rft.epage=17&rft.pages=1-17&rft.issn=0001-8686&rft.eissn=1873-3727&rft.coden=ACISB9&rft_id=info:doi/10.1016/j.cis.2013.10.014&rft_dat=%3Cproquest_cross%3E1551626228%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1551626228&rft_id=info:pmid/24192063&rft_els_id=S0001868613001292&rfr_iscdi=true |